These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 9522032)

  • 1. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion.
    Tanikawa M; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Kodaira T; Hamaoka T
    Arzneimittelforschung; 1993 Jan; 43(1):35-9. PubMed ID: 8447844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats.
    Ishizaki K; Kinbara S; Kawamura M; Kimura K; Shiratori K; Takeuchi T
    Pancreas; 2003 Jan; 26(1):87-91. PubMed ID: 12499923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulative effects of saponin from kikyo-to, a Japanese herbal medicine, on pancreatic exocrine secretion of conscious rats.
    Arai I; Komatsu Y; Hirai Y; Shingu K; Ida Y; Yamaura H; Yamamoto T; Kuroiwa Y; Sasaki K; Taguchi S
    Planta Med; 1997 Oct; 63(5):419-24. PubMed ID: 9342945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological profiles of loxiglumide, a novel cholecystokinin-A receptor antagonist.
    Fukamizu Y; Nakajima T; Kimura K; Kanda H; Fujii M; Saito T; Kasai H
    Arzneimittelforschung; 1998 Jan; 48(1):58-64. PubMed ID: 9522034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
    Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
    Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
    Nakano S; Tachibana I; Otsuki M
    Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved.
    Le Dréan G; Le Huërou-Luron I; Gestin M; Romé V; Bernard C; Chayvialle JA; Fourmy D; Guilloteau P
    Can J Physiol Pharmacol; 2000 Oct; 78(10):813-9. PubMed ID: 11077982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.
    Moriyoshi Y; Shiratori K; Iwabe C; Watanabe S; Takeuchi T
    J Gastroenterol; 1996 Apr; 31(2):249-53. PubMed ID: 8680546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
    Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K
    Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
    Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
    J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cholecystokinin in the intestinal phase of pancreatic circulation in dogs.
    Nakajima M; Naruse S; Kitagawa M; Ishiguro H; Jin C; Ito O; Hayakawa T
    Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G614-20. PubMed ID: 11254487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
    Nakano S; Kihara Y; Otsuki M
    Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide.
    Ito H; Sogabe H; Nakarai T; Sato Y; Tomoi M; Kadowaki M; Matsuo M; Tokoro K; Yoshida K
    J Pharmacol Exp Ther; 1994 Feb; 268(2):571-5. PubMed ID: 7509389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.